The Carlyle Group to Sell Qualicaps to Mitsubishi Chemical Holdings

Global alternative asset manager The Carlyle Group announced that it has agreed to sell its entire shareholdings in Qualicaps to Mitsubishi Chemical Holdings, a Japanese Holding Company mainly operates the leading Chemical and Healthcare businesses. Further details of the transaction were not disclosed. The transaction is subject to regulatory approvals and is expected to close in March 2013. Read the full story here. 

More News:

• 05/17/2013 Northwest Analytics Launches Next Generation Enterprise Manufacturing Intelligence SolutionFrom Northwest Analytics

  NWA Focus EMI Delivers Real Time Process Intelligence and Unique Accelerating Modules - a Shared Knowledge Base and Manufacturing-Centric Collaboration

• 05/16/2013 Innovative Clinical Development Partnership Announced By Quintiles and Merck SeronoFrom MarketWatch.com

  Agreement creates unique strategic collaboration for development and clinical trial execution

• 05/16/2013 $15 Billion Myland Offer Rejected By ActavisFrom Bloomberg.com

  Actavis has rejected drugmaker Mylan Inc's cash-and-stock offer for $15 billion. They have decided to continue talks to take over Warner Chilcott Plc instead, sources have said.

• 05/15/2013 Rapid Micro Biosystems Offers Workshops at New European Headquarters in MunichFrom Rapid Micro Biosystems

  Company hosts hands-on demonstrations of its Growth Direct System

• 05/13/2013 Amgen, Zhejiang Beta Pharma Form Joint VentureFrom FOX Business

  Amgen will form a joint venture with Chinese pharma firm to bring its colon cancer drug Vectibix to the Chinese market

• 05/13/2013 Academic Tech Transfer Collaboration Required for Pharma R&D ModelFrom IT News Online

  Pharma R&D Model Needs Academic Tech Transfer Collaboration for the Future of Drug Innovation Says New Report

• 05/09/2013 CEM Wins Solid-Phase Peptide Synthesis Patent DisputeFrom CEM

  CEM's European Patent covering microwave assisted solid phase peptide synthesis has been upheld in an oral proceeding

• 05/08/2013 Biosimilars Market Prediction Up 20 Percent from 2012From Drug Store News

  New report forecasts global $2.445 billion market this year

• 05/08/2013 Cholesterol Drugs Could Help Kidney Cancer SurvivalFrom HealthDay News

  Study finds statin medications tied to lower death risk after nearly four years of follow-up

• 05/07/2013 Thermo Fisher Scientific Launches Online Configuration ToolFrom Thermo Fisher Scientific

  iAutomate software reduces time needed for optimal system set-up design and provides accurate estimates

• All news »